1/ Your 56-year-old patient with DM2, HTN, HLD, and a prior MI, comes to clinic reporting he stopped his statin a few weeks ago. “The muscle cramps were killing me, doc,” he tells you.

Let's take a deep dive into statin intolerance 💊🩺🫀

#tweetorial #statinintolerance 2/ We’ll cover these 4 Learning Objectives:

🔺List the indications for statin therapy as 1º prevention.

🔺Define statin intolerance (SI).

🔺Understand the prevalence of SI and its impact on mortality.

🔺Develop an approach to statin intolerance.

1/ You see a 56 y.o man with a h/o HTN, DM2 & HLD in your clinic. He’s been out of care for a while and you’re concerned about his ASCVD risk. You order a lipid panel, but wonder, “should I also add an ApoB level?”

Keep reading this @CardioNerds #tweetorial to learn more…! 2/ We’ll cover these 3 Learning Objectives

🔺Describe the role of ApoB in atherogenesis

🔺Understand the data comparing ApoB to other measures of atherogenicity

🔺Identify the practical advantages of using ApoB as a biomarker and when to order it